DeepMedFake-Assisted Detection of Synthetic and Discordant Medical Images

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBeijing Friendship Hospital

About this trial

This prospective randomized controlled trial will evaluate whether DeepMedFake improves the identification of medical images that require further verification. DeepMedFake is an artificial intelligence-based medical image analysis system that provides an image-authenticity risk assessment, a patient-image consistency risk assessment and a recommendation regarding further verification. Hospital physicians and healthcare audit professionals will participate in a randomized two-period crossover design. Each participant will assess one case set with DeepMedFake assistance and the other without AI assistance. The primary outcome in each cohort is the sensitivity of the final verification decision, evaluated separately in the hospital clinical and healthcare audit cohorts.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Aged 18 years or older.

Able to complete reading periods and all required electronic study procedures.

Completed the standardized study training and practice cases.

Provided written informed consent before participation.

Disqualifiers

Direct involvement in development of the locked DeepMedFake model, determination of model weights or selection of decision thresholds.

Direct involvement in selection or construction of the formal case library or adjudication of the reference standard.

Direct involvement in generation or implementation of the reader randomization sequence.

Previous participation as a reader in the pilot study.

Trial design

Design model

Crossover

Treatments tested in this trial

  • DeepMedFake

    Device

    DeepMedFake is an artificial intelligence-based medical image analysis system designed to support the detection of synthetic medical images and authentic medical images paired with discordant patient information. It provides an image-authenticity risk assessment, a patient-image consistency risk assessment and a recommendation regarding further verification. In this study, DeepMedFake is used as a decision-support tool to assist participants in determining whether the image requires further verification before downstream clinical or healthcare audit use. Final judgments and verification decisions are made by the participants.

Treatment groups

64 Participants
are divided into 4 treatment groups
Group A: Crossover Sequence AExperimental treatment 1 intervention
Group B: Crossover Sequence BExperimental treatment 1 intervention
Group C: Crossover Sequence CExperimental treatment 1 intervention
Group D: Crossover Sequence DExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Reader Performance With and Without DeepMedFake Assistance: Sensitivity of the Final Verification Decision in the Hospital Clinical Cohort

The percentage of reference-standard abnormal cases assigned to further verification by hospital physicians will be estimated under DeepMedFake-assisted and unassisted review. The effect measure is the absolute percentage-point difference between review conditions.

Time frame
During both reading periods, up to 4 weeks after randomization
2

Reader Performance With and Without DeepMedFake Assistance: Sensitivity of the Final Verification Decision in the Healthcare Audit Cohort

The percentage of reference-standard abnormal cases assigned to further verification by healthcare audit professionals will be estimated under DeepMedFake-assisted and unassisted review. The effect measure is the absolute percentage-point difference between review conditions.

Time frame
During both reading periods, up to 4 weeks after randomization

Secondary outcomes

1

Reader Performance With and Without DeepMedFake Assistance: Specificity of the Final Verification Decision in the Hospital Clinical Cohort

The percentage of authentic, information-matched cases assigned to no further verification by hospital physicians will be estimated under each review condition and compared between conditions.

Time frame
During both reading periods, up to 4 weeks after randomization
2

Reader Performance With and Without DeepMedFake Assistance: Specificity of the Final Verification Decision in the Healthcare Audit Cohort

The percentage of authentic, information-matched cases assigned to no further verification by healthcare audit professionals will be estimated under each review condition and compared between conditions.

Time frame
During both reading periods, up to 4 weeks after randomization
3

Sensitivity of the Final Verification Decision for Synthetic Medical Image Cases

The percentage of reference-standard synthetic-image cases assigned to further verification will be estimated under each review condition. DeepMedFake-assisted and unassisted review will be compared separately within the hospital clinical and healthcare audit cohorts.

Time frame
During both reading periods, up to 4 weeks after randomization
4

Sensitivity of the Final Verification Decision in Discordant Cases

The percentage of authentic images paired with discordant patient information that are assigned to further verification will be estimated under each review condition. DeepMedFake-assisted and unassisted review will be compared separately within the hospital clinical and healthcare audit cohorts.

Time frame
During both reading periods, up to 4 weeks after randomization

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: